ALISAR

This brand name is authorized in Nigeria.

Active ingredients

The drug ALISAR contains one active pharmaceutical ingredient (API):

1	Tretinoin UNII 5688UTC01R - TRETINOIN
	Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones.
	Read more about Tretinoin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100616	Cream	ALISAR CREAM 0.025 CREAM 0.025% 1 X 30G	17 NF-PP-361595 ALISAR CREAM 0.025 TRETINOIN 0.025%w/w TRETINOIN USP 0.025% w/w, cream base A4-100616 Drugs Imported Products 130G Prescription Only Medicine (POM) 9/7/2023 VENCHURA PHARMACEUTICALS LIMITED, MERCY ENELI STREET, SURULERE LAGOS 565677887 churavencent1313@gmail.com Claroid Pharmaceuticals Private Limited, 217/P, Opp. Gurukul English Medium School, Kamod Pirana Road, Tal. - Daskroi, Dist.- Ahmedabad - 382425 India, India	30/11/2023
A4-100617	Cream	ALISAR CREAM 0.05 CREAM 0.05% 1 X 30G	16 NF-PP-361593 ALISAR CREAM 0.05 TRETINOIN 0.05%W/W TRETINOIN USP 0.05% w/w, cream base A4-100617 Drugs Imported Products 130G Prescription Only Medicine (POM) 9/7/2023 VENCHURA PHARMACEUTICALS LIMITED, MERCY ENELI STREET, SURULERE LAGOS 565677887 churavencent1313@gmail.com Claroid Pharmaceuticals Private Limited, 217/P, Opp. Gurukul English Medium School, Kamod Pirana Road, Tal. - Daskroi, Dist.- Ahmedabad - 382425 India, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AD01	Tretinoin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AD Retinoids for topical use in acne
Discover more medicines within D10AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100616, A4-100617